SynthesisBMC health services research2026

Cost-effectiveness analysis of the treatment pathway after trastuzumab treatment failure in patients with HER2-positive advanced breast cancer: a chinese health system perspective.

Tianqi Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.